ロード中...
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
BACKGROUND: A new human myeloma cell line, MMLAL, was established from the myelomatous pleural effusion of a 73-year-old Chinese patient suffering from symptomatic International stage III IgG/lambda myeloma. After a brief period of complete remission, he developed aggressive systemic relapse complic...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3866931/ https://ncbi.nlm.nih.gov/pubmed/24330858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-13-122 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|